buy this full document at
Moscou: Pharmacology for Pharmacy Technicians
Test Bank
Chapter 1: Fundamentals of Pharmacology
TRUE/FALSE
1. Drugs come only from natural origins.
ANS: F
Drugs may come from natural or synthetic origin.
DIF:
Cognitive level 2: Interpretation
REF: p. 5
2. Erythropoietin is an example of a biopharmaceutical.
ANS: T
Erythropoietin and human insulin are examples of biopharmaceuticals.
DIF:
Cognitive level 1: Recall
REF: p. 3
3. Generic drugs are always less expensive than brand name drugs.
ANS: T
Generic drugs are always less expensive than brand name drugs.
DIF:
Cognitive level 2: Interpretation
REF: p. 8
4. “Rx only” must be printed on the label of all legend drugs.
ANS: T
“Rx only” must be printed on the label of all legend drugs.
DIF:
Cognitive level 1: Recall
REF: p. 8
5. Binders and fillers are inactive ingredients but have no influence rate of drug absorption.
ANS: F
Binders and fillers are inactive ingredients but they may influence rate of drug absorption.
buy this full document at
Full file at />DIF:
Cognitive level 2: Interpretation
REF: p. 10
MULTIPLE CHOICE
6. _____ drugs are only administered directly into the bloodstream.
a. Enteral
b. Transdermal
c. Transmucosal
d. Parenteral
ANS: D
Parenterally administered drugs directly enter the bloodstream, producing rapid action. Once in
the bloodstream, the side effects cannot be easily stopped.
DIF:
Cognitive level 1: Recall
REF: p. 12
7. Fentanyl is used as an _____.
a. anesthetic
b. analgesic
c. anticoagulant
d. antitussive
ANS: B
Fentanyl is a synthetically manufactured analgesic.
DIF:
Cognitive level 1: Recall
REF: p. 5
8. Which of the following statements about pharmacy technicians is not true: Pharmacy technicians
who possess a good understanding of pharmacology understand the importance of _____.
a. drug interactions
b. therapeutic duplications
c. lab values
d. excessive dose alerts
ANS: C
Knowledge of pharmacology facilitates selection of warning labels for drugs dispensed.
Pharmacy technicians who possess a good understanding of pharmacology understand the
importance of recognizing drug interactions, therapeutic duplications, and excessive dose alerts
screened by the computer
DIF:
Cognitive level 2: Interpretation
REF: p. 3
9. In 1906, the _____ was passed to protect the public from ineffective and harmful drugs.
a. Humphrey-Durham Amendment
Copyright © 2009 by Mosby, Inc., an affiliate of Elsevier Inc.
Full file at />b. Controlled Substance Act
c. Pure Food and Drug Act
d. Combat Meth Act
ANS: C
In 1906, the Pure Food and Drug Act was passed to protect the public from ineffective and
harmful drugs.
DIF:
Cognitive level 1: Recall
REF: p. 5
10. Which of the following drugs were not discovered in the 20th century?
a. antiinfective agents
b. insulin
c. antiretrovirals
d. castor oil
ANS: D
Antiinfective agents, insulin and its use for the treatment of diabetes, and antiretrovirals for the
treatment of HIV/AIDS were all discovered between the 1930s and present time.
DIF:
Cognitive level 1: Recall
REF: p. 3
11. The aim of drug therapy is to _____ disease.
a. diagnose
b. treat
c. cure
d. all of the above
ANS: D
The aim of drug therapy is to diagnose, treat, cure, or lessen the symptoms of disease.
DIF:
Cognitive level 2: Interpretation
REF: p. 5
12. Which step is not part of the drug development process?
a. clinical research
b. clinical studies
c. new drug application process
d. marketing
ANS: D
There are many steps in the drug development process. The steps from the test tube to production
and distribution of a new drug involve preclinical research, clinical studies, new drug application
process, and review.
Copyright © 2009 by Mosby, Inc., an affiliate of Elsevier Inc.
Full file at />DIF:
Cognitive level 2: Interpretation
REF: p. 5
13. The proprietary name of a drug is assigned by the _____.
a. FDA
b. CDER Labeling and Nomenclature Committee
c. New Drug Application reviewer
d. manufacturer
ANS: D
The proprietary name or brand name is assigned by the drug manufacturer according to
recommendations made by the CDER Labeling and Nomenclature Committee.
DIF:
Cognitive level 1: Recall
REF: p. 8
14. The Combat Methamphetamine Epidemic Act of 2005 (CMEA) was signed into law on March 6,
2006, to regulate, among other things, retail over-the-counter sales of _____.
a. ephedrine
b. pseudoephedrine
c. phenylpropanolamine products
d. all of the above
ANS: D
The Combat Methamphetamine Epidemic Act of 2005 (CMEA) was signed into law on March 6,
2006, to regulate, among other things, retail over-the-counter sales of ephedrine,
pseudoephedrine, and phenylpropanolamine products.
DIF:
Cognitive level 1: Recall
REF: p. 9
15. Chemical properties of the drug influence _____ of the drug in the body.
a. absorption
b. distribution
c. metabolism and elimination
d. all of the above
ANS: D
Chemical properties of the drug influence absorption, distribution, metabolism, and elimination
of the drug in the body.
DIF:
Cognitive level 1: Recall
REF: p. 10
MATCHING
Match the following drug endings with their classifications.
a. “-olol”
Copyright © 2009 by Mosby, Inc., an affiliate of Elsevier Inc.
Full file at />b.
c.
d.
e.
16.
17.
18.
19.
20.
“-prazole”
“-depine”
“-thromycin”
“-profen”
calcium channel blocker
β-adrenergic blocking drug
NSAID
macrolide anti-infective
proton pump inhibitor
16. ANS:
MSC:
17. ANS:
MSC:
18. ANS:
MSC:
19. ANS:
MSC:
20. ANS:
MSC:
C
DIF: Cognitive level 1: Recall
REF:
See Table 1-1 with common endings to official drug names.
A
DIF: Cognitive level 1: Recall
REF:
See Table 1-1 with common endings to official drug names.
E
DIF: Cognitive level 1: Recall
REF:
See Table 1-1 with common endings to official drug names.
D
DIF: Cognitive level 1: Recall
REF:
See Table 1-1 with common endings to official drug names.
B
DIF: Cognitive level 1: Recall
REF:
See Table 1-1 with common endings to official drug names.
p. 8
p. 8
p. 8
p. 8
p. 8
Match the following controlled substances with their schedule.
a. marijuana
b. methylphenidate
c. diazepam
d. diphenoxylate and buprenorphine
e. methyltestosterone
21.
22.
23.
24.
25.
C-III
C-II
C-V
C-I
C-IV
21. ANS:
MSC:
22. ANS:
MSC:
23. ANS:
MSC:
24. ANS:
MSC:
25. ANS:
MSC:
E
DIF: Cognitive level 1: Recall
Taken from Table 1-3 of controlled substance schedules.
B
DIF: Cognitive level 1: Recall
Taken from Table 1-3 of controlled substance schedules.
D
DIF: Cognitive level 1: Recall
Taken from Table 1-3 of controlled substance schedules.
A
DIF: Cognitive level 1: Recall
Taken from Table 1-3 of controlled substance schedules.
C
DIF: Cognitive level 1: Recall
Taken from Table 1-3 of controlled substance schedules.
REF: p. 9
REF: p. 9
REF: p. 9
REF: p. 9
REF: p. 9
Copyright © 2009 by Mosby, Inc., an affiliate of Elsevier Inc.